Hearing loss in the US adult population is linked to hospitalization, poorer self-reported health, hypertension, diabetes, and tobacco use. Because iron deficiency anemia (IDA) is a common and easily correctable condition, further understanding of the association between IDA and all types of hearing loss in a population of US adults may help to open new possibilities for early identification and appropriate treatment.
1
Hearing loss increases with each decade of life, affecting 40% to 66% of adults older than 65 years and 80% of those older than 85 years. 2, 3 Risk factors for earlier onset of adult hearing loss include hypertension, diabetes, and tobacco use. 3, 4 Sudden sensorineural hearing loss (SNHL) is characterized by a rapid deterioration in hearing function that occurs in less than a 72-hour period. The mechanism is unknown, but a recent study by Chung et al 5 found a significant association between iron deficiency anemia (IDA) and sudden SNHL (odds ratio [OR], 1.34; 95% CI, 1.11-1.61; P < .01), which was most prominent in patients younger than 60 years. Iron deficiency anemia is a subset of anemia in which patients exhibit low hemoglobin, serum ferritin, and serum iron levels and increased soluble transferrin receptor levels. In US adults, IDA is usually a result of blood loss and often responds well to reversal of the source of blood loss and oral iron supplementation. 6 Although the role of iron in the inner ear has not been clearly established, blood supply to this area is highly sensitive to ischemic damage. Sudden SNHL may have a vascular cause potentially exacerbated by IDA as described in a rat model of iron deficiency and sudden SNHL. This study identified defects in the cochlea, including strial atrophy 7 and reduced spiral ganglion cells, with effects on the stereocilia of the inner and outer hair cells. 7, 8 The role of iron in the vasculature and nervous system raises the possibility of its association with other common types of adult hearing loss beyond sudden SNHL. Because IDA is a common and reversible condition, further understanding of the association between IDA and all types of hearing loss in a population of US adults may open new possibilities for treatment. Thus, the objective of this study was to examine the association between IDA and SNHL, conductive hearing loss (CHL), and combined hearing loss among a cohort of adult patients aged 21 to 90 years. Based on previous reports 5 of sudden SNHL and the mechanical component involved in CHL, the hypothesis was that IDA would demonstrate a stronger association with SNHL compared with CHL.
Methods

Study Population
We performed a retrospective cohort study using data obtained from deidentified electronic medical records from the Penn State Milton S. Hershey Medical Center in Hershey, Pennsylvania. Data were extracted using the National Institutes of Health-supported Informatics for Integrating Biology and the Bedside electronic medical records query tool. Patients were identified as having hearing loss if they had at least 1 encounter associated with 1 of the following spectra of ICD-9 codes: 389.0 (CHL), 389.1 (SNHL), or 389 (combined hearing loss). Patients meeting these criteria for hearing loss were categorized as having CHL, SNHL, or combined hearing loss. Combined hearing loss was defined as any combination of CHL, SNHL, deafness, and unspecified hearing loss. Covariates included age (21-69 and ≥70 years) and sex (male and female). Hearing loss-related ICD-9 codes may have been added by a primary care physician, otolaryngologist, or audiologist following a visit with a hearing-related symptom. Formal audiogram testing would not be required for a clinician to select 1 of these codes.
Statistical Analysis
Prevalence of IDA and hearing loss are reported. Two-sided χ 2 testing was performed and ORs were determined via 2 × 2 contingency tables. In addition, multivariate conditional logistic regression analysis (adjusted for sex) was performed to obtain adjusted ORs and 95% CIs. All statistical testing was performed using R, version 3.2.3 software (The R Project for Statistical Computing).
Results
Demographics
Overall, a total of 305 339 individuals aged 21 to 90 years were identified in the study population. Of these, 132 551 were men (43.4%); mean (SD) age was 50.1 (18.5) years. This cohort was identified as having at least 1 outpatient, inpatient, or emergency department visit at Penn State Hershey Medical Center from 2011 to 2015. The prevalence of IDA was 0.7% (n = 2274). Consistent with published data, 19 IDA was more prevalent in
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Meaning Additional studies to examine how iron supplementation influences hearing status are warranted. women compared with men (prevalence, 1.1% vs 0.3%; P < .001). The prevalence of combined hearing loss was 1.6% (n = 4807), and SNHL (0.7%) was more prevalent than CHL (0.2%). Iron deficiency anemia was positively associated with both SNHL (1.1%; P = .005) and the presence of combined hearing loss (3.4%; P < .001) ( Table 1) .
Association of IDA and Hearing Loss
After adjustment for sex, IDA remained associated with an increased odds of combined hearing loss (adjusted OR, 2.41; 95% CI, 1.90-3.01). Similarly, IDA was associated with increased odds of SNHL (adjusted OR, 1.82; 95% CI, 1.18-2.66) in the adjusted analysis ( Table 2) . Serum ferritin and hemoglobin are not usually tested unless the diagnosis warrants it; to account for this potential underrepresentation of individuals with IDA, a sensitivity analysis was performed using an IDA prevalence of 3% for women and 1% for men. Overall, similar results were seen, indicating increased odds of both SNHL and combined hearing loss with IDA (eTable in the Supplement).
Discussion
Our study demonstrates increased odds of hearing loss among adults aged 21 to 90 years with IDA. These findings are consistent with those of another observational study in Taiwan that identified an association between IDA and sudden SNHL most prominently in individuals younger than 60 years. 5 Previous studies 7, 8, [20] [21] [22] [23] [24] [25] [26] suggest several potential mechanisms by which IDA may affect hearing health; however, it is unknown whether early diagnosis and treatment of IDA could positively affect the overall health status of adults with hearing loss. The cochlea is highly susceptible to ischemic damage since only the labyrinthine artery supplies blood to this area. 27 Iron deficiency anemia has been demonstrated to be a potential risk factor for ischemic stroke due to lower hemoglobin levels leading to impaired oxygen-carrying capacity. The present study found an association between IDA and hearing loss. Iron deficiency anemia is easily treated with several months of oral iron supplementation. 6 A study using the NHANES data from 1999-2002 found that individuals with healthier dietary habits were able to detect higher-frequency noises. 36 Treatment of IDA will naturally improve anemia and replenish iron stores. Iron deficiency anemia is associated with a large number of related morbidities (eg, fatigue and reduced work capacity), which are also likely to improve with treatment. [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] Additional studies are needed to determine whether there is a link between iron supplementation and hearing status.
Limitations
There are limitations to this analysis that should be considered. The use of laboratory results (ie, serum ferritin and hemoglobin levels) increased the specificity of the IDA definition in our study but reduced the sensitivity. With the wide availability of laboratories not affiliated with our institution and with Informatics for Integrating Biology and the Bedside unable to include data that are not internal, the prevalence of IDA and hearing loss in this study may be falsely reduced. A sensitivity analysis was performed to address this limitation. Using an IDA prevalence of 1% for men and 3% for women, the same analyses were performed. The data remained significant, indicating that although the sensitivity of the analysis is reduced by the present methods, the positive association between IDA and hearing loss remains (eTable in the Supplement). In addition, identifying whether iron deficiency or anemia alone is associated with hearing loss is unable to be accurately performed with this analysis since hemoglobin and serum ferritin are not often tested in the general population. Therefore, distinguishing between iron deficiency, anemia, and IDA would not be definitive.
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